title: [Effects of PML-RARalpha on cAMP-induced AML cell differentiation].
abstract: To explore the molecular mechanisms of acute promyelocytic leukemia cell differentiation induced by cAMP combined with low-dose As2O3, the PR9 cell line, which was stably transfected by PML-RARa fusion gene, was used as in vitro model. The effects of PML-RARa on cAMP-induced AML cell differentiation were evaluated according to cell growth, cell morphology, cell surface antigen as well as luciferase reporter gene assay, in the cells before and after the treatment with cAMP and/or As2O3. The results showed that cAMP alone could slightly increase the expression of CD11b in the PR9 cells expressing the PML-RARa fusion protein, but could not induce these cells to differentiate. The cells presented the terminal differentiation morphology and significantly increased CD11b expression only under the treatment of cAMP combined with As2O3. In addition, PML-RARa had strong inhibitory activity on the transcription of the reporter gene containing cAMP response elements. In conclusions, the PML-RARa fusion protein could dramatically block the signaling pathway of cAMP during the AML cell differentiation.
authors.affiliation: National Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University Medical College, Shanghai 200025, China.
authors.forename: Pei-Min
authors.initials: PM
authors.lastname: Jia
authors.forename: Ai-Xia
authors.initials: AX
authors.lastname: Dou
authors.forename: Chang-Lin
authors.initials: CL
authors.lastname: Zhang
authors.forename: Ye-Jiang
authors.initials: YJ
authors.lastname: Lou
authors.forename: Xiao-Rong
authors.initials: XR
authors.lastname: Pan
authors.forename: Jian-Hua
authors.initials: JH
authors.lastname: Tong
mesh_terms: D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects*; D045744:Cell Line, Tumor; D000242:Cyclic AMP / Q000378:metabolism* / Q000494:pharmacology; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000378:metabolism*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D010087:Oxides / Q000494:pharmacology; D015398:Signal Transduction; D014162:Transfection
chemical_list: D001152:Arsenicals; D015514:Oncogene Proteins, Fusion; D010087:Oxides; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D000242:Cyclic AMP; D000077237:Arsenic Trioxide